Vimarsana
Biggest News Aggregation in the World

Page 3 - Scott Kellen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Kellen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Kellen Today - Breaking & Trending Today

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors - Vimarsana News

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

MINNEAPOLIS--(BUSINESS WIRE)--Jul 15, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the election of two industry veterans to the Company’s Board of Directors. Amy Burroughs, President and CEO of Cleave Therapeutics, brings over 20 years of experience in business and commercial development, strategy and leadership in the pharmaceutical industry. Dr. Charles Semba, Chief Medical Officer of Eluminex Biosciences, has over 20 years of drug-deve...

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results - Vimarsana News

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results May 5, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--May 5, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2021. DiaMedica will host a conference call Thursday, May 6, 2021, at 7:00 a.m. Cen...

Source: apnews.com
DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke - Vimarsana News

DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke

Press release content from Business Wire. The AP news staff was not involved in its creation. DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke March 9, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--Mar 9, 2021-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel treatments for neurological and kidney diseases, today announced that it will host a key opinion leader (KOL) webinar on DM199, the Company’s lead asset for the treatment of Acute Ischemic Stroke (AIS), on Friday, March 19, 2021 at...

Source: apnews.com